Ionis Pharmaceuticals Inc (IONS)

Trade IONS now with
9/23/2022 2:28:47 AM Ionis Pharma Says Phase 2bSOLANO Study For Patients With Hypercholesterolemia Meets Primary Endpoint
9/7/2022 2:33:47 AM Ionis Presents Positive Results From Phase 3 NEURO-TTRansform Study On Amyloidosis
7/26/2022 7:33:02 AM Ionis Says FDA Accepts NDA, Grants Priority Review Of Tofersen For Rare, Genetic Form Of ALS
7/11/2022 7:11:21 AM Ionis Pharma: Roche To Advance IONIS-FB-LRx Into Phase 3 Study In Patients With Immunoglobulin A Nephropathy
6/25/2022 9:58:38 AM Ionis Presents Positive Phase 2b Data For Chronic Hepatitis B Treatment At EASL International Liver Congress
6/3/2022 5:23:01 AM Ionis :Biogen Says Results From Phase 3 Study And Open-label Extension Of Tofersen Shows Clinical Benefit In SOD1-ALS
4/4/2022 12:20:51 AM Ionis Presents Positive Data For ETESIAN Phase 2b Study Of Antisense Medicine Targeting PCSK9 At 2022 ACC
3/28/2022 7:34:53 AM Biogen : Phase 1 Study Of BIIB078 On Amyotrophic Lateral Sclerosis Did Not Meet Any Secondary Efficacy Endpoints
2/24/2022 7:22:51 AM Ionis Q4 EPS $1.41 Vs. Loss/shr $2.54 Prior Year
1/31/2022 7:08:17 AM Pfizer, Ionis Announce Discontinuation Of Vupanorsen Clinical Program For CV Risk Reduction And Hypertriglyceridemia